This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Amtoft, H. W. Articles by Pedersen, F. S. Search for Related Content PubMed PubMed Citation Articles by Amtoft, H. W. Articles by Pedersen, F. S.

 Previous Article  |  Next Article 

J. Virol., Jul 1997, 5080-5087, Vol 71, No. 7
Copyright © 1997, American Society for Microbiology

Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants

HW Amtoft, AB Sorensen, C Bareil, J Schmidt, A Luz and FS Pedersen
Department of Molecular and Structural Biology, University of Aarhus, Aarhus C, Denmark.

Murine retrovirus SL3-3 is highly T lymphomagenic. Its pathogenic properties are determined by the transcriptional enhancer of the U3 repeat region which shows preferential activity in T cells. Within the U3 repeats, the major determinant of T-cell specificity has been mapped to binding sites for the AML1 transcription factor family (also known as the core binding factor [CBF], polyomavirus enhancer binding protein 2 [PEBP2], and SL3-3 enhancer factor 1 [SEF-1]). SL3-3 viruses with AML1 site mutations have lost a major determinant of T-cell-specific enhancer function but have been found to retain a lymphomagenic potential, although disease induction is slower than for the SL3-3 wild type. To compare the specificities and mechanisms of disease induction of wild-type and mutant viruses, we have examined lymphomas induced by mutant viruses harboring transversions of three consecutive base pairs critical to AML1 site function (B. Hallberg, J. Schmidt, A. Luz, F. S. Pedersen, and T. Grundstrom. J. Virol. 65:4177-4181, 1991). Our results show that the mutated AML1 sites are genetically stable during lymphomagenesis and that ecotropic provirus numbers in DNA of tumors induced by wild-type and mutant viruses fall within the same range. Moreover, proviruses were found to be integrated at the c-myc locus in similar proportions of wild-type and mutant SL3-3-induced tumors, and the mutated AML1 sites of proviruses at c-myc are unaltered. In some cases, however, including one c-myc-integrated provirus, a single-base pair change was detected in a second, weaker AML1 binding site. By DNA rearrangement analysis of the T-cell receptor beta-locus, tumors induced by the AML1 site mutants are found to be of the T-cell type. Thus, although the AML1 site mutants have weakened T-cell-specific enhancers they are T-lymphomagenic, and wild-type- and mutant-virus- induced tumor DNAs are similar with respect to the number of overall ecotropic and c-myc-integrated clonal proviruses. The SL3-3 wild-type and AML1 site mutant viruses may therefore induce disease by similar mechanisms.

This article has been cited by other articles:

• Mertz, J. A., Kobayashi, R., Dudley, J. P. (2007). ALY Is a Common Coactivator of RUNX1 and c-Myb on the Type B Leukemogenic Virus Enhancer. J. Virol. 81: 3503-3513 [Abstract] [Full Text]  
• Nielsen, A. A., Sorensen, A. B., Schmidt, J., Pedersen, F. S. (2005). Analysis of Wild-Type and Mutant SL3-3 Murine Leukemia Virus Insertions in the c-myc Promoter during Lymphomagenesis Reveals Target Site Hot Spots, Virus-Dependent Patterns, and Frequent Error-Prone Gap Repair. J. Virol. 79: 67-78 [Abstract] [Full Text]  
• Dai, K.-Z., Johansen, F.-E., Kolltveit, K. M., Aasheim, H.-C., Dembic, Z., Vartdal, F., Spurkland, A. (2004). Transcriptional Activation of the SH2D2A Gene Is Dependent on a Cyclic Adenosine 5'-Monophosphate-Responsive Element in the Proximal SH2D2A Promoter. J. Immunol. 172: 6144-6151 [Abstract] [Full Text]  
• Rulli, K., Lenz, J., Levy, L. S. (2002). Disruption of Hematopoiesis and Thymopoiesis in the Early Premalignant Stages of Infection with SL3-3 Murine Leukemia Virus. J. Virol. 76: 2363-2374 [Abstract] [Full Text]  
• Sørensen, A. B., Lund, A. H., Ethelberg, S., Copeland, N. G., Jenkins, N. A., Pedersen, F. S. (2000). Sint1, a Common Integration Site in SL3-3-Induced T-Cell Lymphomas, Harbors a Putative Proto-Oncogene with Homology to the Septin Gene Family. J. Virol. 74: 2161-2168 [Abstract] [Full Text]  
• Ethelberg, S., Tzschaschel, B. D., Luz, A., Diaz-Cano, S. J., Pedersen, F. S., Schmidt, J. (1999). Increased Induction of Osteopetrosis, but Unaltered Lymphomagenicity, by Murine Leukemia Virus SL3-3 after Mutation of a Nuclear Factor 1 Site in the Enhancer. J. Virol. 73: 10406-10415 [Abstract] [Full Text]  
• Schmidt, J., Lumniczky, K., Tzschaschel, B. D., Guenther, H. L., Luz, A., Riemann, S., Gimbel, W., Erfle, V., Erben, R. G. (1999). Onset and Dynamics of Osteosclerosis in Mice Induced by Reilly-Finkel-Biskis (RFB) Murine Leukemia Virus : Increase in Bone Mass Precedes Lymphomagenesis. Am. J. Pathol. 155: 557-570 [Abstract] [Full Text]  
• Lewis, A. F., Stacy, T., Green, W. R., Taddesse-Heath, L., Hartley, J. W., Speck, N. A. (1999). Core-Binding Factor Influences the Disease Specificity of Moloney Murine Leukemia Virus. J. Virol. 73: 5535-5547 [Abstract] [Full Text]  
• Lund, A. H., Schmidt, J., Luz, A., Sørensen, A. B., Duch, M., Pedersen, F. S. (1999). Replication and Pathogenicity of Primer Binding Site Mutants of SL3-3 Murine Leukemia Viruses. J. Virol. 73: 6117-6122 [Abstract] [Full Text]  
• DiFronzo, N. L., Holland, C. A. (1999). Sequence-Specific and/or Stereospecific Constraints of the U3 Enhancer Elements of MCF 247-W Are Important for Pathogenicity. J. Virol. 73: 234-241 [Abstract] [Full Text]  
• Lovmand, J., Sorensen, A. B., Schmidt, J., Ostergaard, M., Luz, A., Pedersen, F. S. (1998). B-Cell Lymphoma Induction by Akv Murine Leukemia Viruses Harboring One or Both Copies of the Tandem Repeat in the U3 Enhancer. J. Virol. 72: 5745-5756 [Abstract] [Full Text]